JOA - 2026-10-07 - Journal Article
Integrating the Association Research Circulation Osseous Clinical Practice Guideline into the Diagnosis and Management of Osteonecrosis of the Femoral Head: Four Illustrative Case Scenarios.
Thomas G, Mirzaei A, Mont MA, Cheng EY
Topics
Key Takeaway
Four illustrative ONFH cases demonstrate application of the first international ARCO evidence-based CPG, covering observation, core decompression with bone marrow concentrate, and THA across lesion sizes and collapse risk strata.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This paper applies the newly released ARCO international clinical practice guideline for nontraumatic ONFH to four illustrative cases spanning asymptomatic small lesions, symptomatic pre-collapse disease, bilateral ONFH requiring staged joint-preserving and arthroplasty management, and asymptomatic large lesions in older patients. Decision nodes addressed include MRI-based diagnosis, collapse risk estimation, core decompression with bone marrow concentrate augmentation, and THA selection. No outcome data are reported; the paper functions solely as a CPG implementation guide.
Key Limitation
No treatment outcomes are reported for any case, so the clinical validity and superiority of ARCO CPG-directed management over prior practice patterns cannot be assessed.
Original Abstract
BACKGROUND
Treatment choices for osteonecrosis of the femoral head (ONFH) are based on the patient's age, risk of collapse, lesion size, symptoms, and disease stage. To our knowledge, this represents the first international, evidence-based clinical practice guideline (CPG) developed specifically for the diagnosis and treatment of nontraumatic ONFH, which was recently released by the Association Research Circulation Osseous (ARCO). The CPG offers recommendations that are supported by evidence, but their practical implementation in day-to-day clinical practice may be less intuitive. These case scenarios illustrate the application of the CPG only and do not discuss treatment outcomes, which are discussed in the CPG itself.
METHODS
To illustrate how ARCO CPG recommendations can be applied to a range of ONFH presentations, four relevant clinical cases were chosen. The selection of imaging, evaluation of symptoms, estimation of collapse risk, grounds for observation, use of joint-preserving techniques, and consideration of total hip arthroplasty (THA) are all important diagnostic and therapy choices that are highlighted in each case.
RESULTS
For small, asymptomatic lesions with little chance of collapse, Case 1 illustrates the value of magnetic resonance imaging in the diagnosis and the suitability of observation. Case 2 shows how core decompression and bone marrow concentrate augmentation can be used to treat symptomatic pre-collapse disease. Case 3 illustrates the decision-making process for a young patient who has bilateral ONFH and needs joint-preserving therapy for the contralateral pre-collapse lesion and THA for one hip with collapse. Case 4 illustrates how patient age, lesion size, and symptom status affect the decision to choose observation over intervention for asymptomatic illness.
CONCLUSION
The ARCO CPG provides a practical framework for diagnosis, risk stratification, and treatment selection in patients who have ONFH. Application of the guideline recommendations can facilitate evidence-based and patient-centered decision-making across a broad spectrum of clinical scenarios.